![]() |
产地 | France |
品牌 | AntibodySystem |
保存条件 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -320°C long term. |
货号 | RVV09905 |
用途 | ELISA |
应用范围 | 一抗,中和抗体 |
抗原来源 | N/A |
保质期 | 1 year |
抗体名 | 抗 Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein 纳米抗体 (SAA1125) |
是否单克隆 | 是 |
克隆性 | |
靶点 | NP/Nucleoprotein |
适应物种 | Vesicular stomatitis Indiana virus (strain San Juan) (VSIV) |
形态 | Liquid |
宿主 | XtenCHO expression |
标记物 | Unconjugate,cys-tag,ready to conjugate |
包装规格 | 100 μg |
亚型 | VHH,Nanobody |
标识物 | Unconjugate |
浓度 | 1 mg/ml% |
免疫原 | N/A |
是否进口 | 是 |
Tags: 抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)supplier,抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)purchase,抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)manufacturer,抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)distributor,抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)cost,抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)buy,抗Vesicular stomatitis Indiana virus/VSIV NP/Nucleoprotein Nanobody (SAA1125) (纳米抗体)for sale
法国AntibodySystem新推出Magic-XtenNano®纳米抗体,高亲和力,分子量小,自带自由的Cys-tag,便于偶联。
Aiming to develop the most reliable bioreagents, AntibodySystem SAS was founded in 2019 in France by a team of professionals from top industrial companies and research institutes. The collective scientific and technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits and other related products. By working with talented researchers and technicians, AntibodySystem continues to upgrade product qualities and lower the overall cost, offering accountable and affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term and stable collaborations with academia, pharmaceutical industry, biotech companies and research hospitals, supporting their R&D by AntibodySystem's bioreagents with excellent data accuracy and reproducibility.